• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素与阿片类药物的相互作用:对阿片类药物依赖和戒断的影响。

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

机构信息

Department of Neuroscience, Farber Institute for Neurosciences, Thomas Jefferson University, Philadelphia, PA 19107, USA.

出版信息

Neuroscience. 2013 Sep 17;248:637-54. doi: 10.1016/j.neuroscience.2013.04.034. Epub 2013 Apr 24.

DOI:10.1016/j.neuroscience.2013.04.034
PMID:23624062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3742578/
Abstract

Withdrawal from opiates, such as heroin or oral narcotics, is characterized by a host of aversive physical and emotional symptoms. High rates of relapse and limited treatment success rates for opiate addiction have prompted a search for new approaches. For many opiate addicts, achieving abstinence may be further complicated by poly-drug use and co-morbid mental disorders. Research over the past decade has shed light on the influence of endocannabinoids (ECs) on the opioid system. Evidence from both animal and clinical studies point toward an interaction between these two systems, and suggest that targeting the EC system may provide novel interventions for managing opiate dependence and withdrawal. This review will summarize the literature surrounding the molecular effects of cannabinoids and opioids on the locus coeruleus-norepinephrine system, a key circuit implicated in the negative sequelae of opiate addiction. A consideration of the trends and effects of marijuana use in those seeking treatment to abstain from opiates in the clinical setting will also be presented. In summary, the present review details how cannabinoid-opioid interactions may inform novel interventions in the management of opiate dependence and withdrawal.

摘要

阿片类物质(如海洛因或口服麻醉品)戒断的特征是一系列令人不快的身体和情绪症状。阿片类药物成瘾的高复发率和有限的治疗成功率促使人们寻求新的方法。对于许多阿片类药物成瘾者来说,多药物使用和合并精神障碍可能使他们更难达到戒毒。过去十年的研究揭示了内源性大麻素(ECs)对阿片系统的影响。来自动物和临床研究的证据表明这两个系统之间存在相互作用,并表明针对 EC 系统可能为管理阿片类药物依赖和戒断提供新的干预措施。这篇综述将总结围绕大麻素和阿片类药物对蓝斑-去甲肾上腺素系统的分子作用的文献,蓝斑-去甲肾上腺素系统是一个关键的回路,与阿片类药物成瘾的负面后果有关。还将考虑在临床环境中寻求戒除阿片类药物的患者中使用大麻的趋势和影响。总之,本综述详细介绍了大麻素-阿片类药物相互作用如何为阿片类药物依赖和戒断的管理提供新的干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a86/3742578/efdd36e20b4c/nihms-483617-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a86/3742578/3624c47e2dda/nihms-483617-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a86/3742578/8d1f7670b814/nihms-483617-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a86/3742578/efdd36e20b4c/nihms-483617-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a86/3742578/3624c47e2dda/nihms-483617-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a86/3742578/8d1f7670b814/nihms-483617-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a86/3742578/efdd36e20b4c/nihms-483617-f0003.jpg

相似文献

1
Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.大麻素与阿片类药物的相互作用:对阿片类药物依赖和戒断的影响。
Neuroscience. 2013 Sep 17;248:637-54. doi: 10.1016/j.neuroscience.2013.04.034. Epub 2013 Apr 24.
2
Social stress engages opioid regulation of locus coeruleus norepinephrine neurons and induces a state of cellular and physical opiate dependence.社会压力会影响蓝斑核去甲肾上腺素神经元的阿片调节,并导致细胞和身体阿片类药物依赖状态。
Neuropsychopharmacology. 2013 Sep;38(10):1833-43. doi: 10.1038/npp.2013.117. Epub 2013 May 10.
3
The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse.蓝斑核:一个关键核团,应激和阿片类药物在此交汇,共同介导阿片类药物滥用易感性。
Brain Res. 2010 Feb 16;1314:162-74. doi: 10.1016/j.brainres.2009.09.036. Epub 2009 Sep 16.
4
CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence.蓝斑中的CREB(环磷酸腺苷反应元件结合蛋白):在阿片类药物依赖中起作用的生化、生理及行为学证据
J Neurosci. 1997 Oct 15;17(20):7890-901. doi: 10.1523/JNEUROSCI.17-20-07890.1997.
5
Neuroadaptive responses in brainstem noradrenergic nuclei following chronic morphine exposure.慢性吗啡暴露后脑干去甲肾上腺素能核团中的神经适应性反应。
Mol Neurobiol. 2001 Apr-Jun;23(2-3):155-71. doi: 10.1385/mn:23:2-3:155.
6
Opposing regulation of the locus coeruleus by corticotropin-releasing factor and opioids. Potential for reciprocal interactions between stress and opioid sensitivity.促肾上腺皮质激素释放因子和阿片类物质对蓝斑的反向调节。应激与阿片类物质敏感性之间相互作用的可能性。
Psychopharmacology (Berl). 2001 Dec;158(4):331-42. doi: 10.1007/s002130000673. Epub 2001 Mar 14.
7
Role of orexin type-1 receptors in paragiganto-coerulear modulation of opioid withdrawal and tolerance: A site specific focus.食欲素 1 型受体在缰核-蓝斑系统调制阿片类戒断和耐受中的作用:一个特定部位的焦点。
Neuropharmacology. 2017 Nov;126:25-37. doi: 10.1016/j.neuropharm.2017.08.024. Epub 2017 Aug 18.
8
Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.阿片类药物成瘾与蓝斑核。可乐定、纳曲酮、美沙酮和丁丙诺啡的临床应用。
Psychiatr Clin North Am. 1993 Mar;16(1):61-73.
9
Advances in the field of cannabinoid--opioid cross-talk.大麻素 - 阿片类物质相互作用领域的进展
Addict Biol. 2008 Jun;13(2):213-24. doi: 10.1111/j.1369-1600.2008.00107.x.
10
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.CB1受体基因敲除小鼠对大麻素无反应及阿片类药物成瘾作用减弱
Science. 1999 Jan 15;283(5400):401-4. doi: 10.1126/science.283.5400.401.

引用本文的文献

1
Design, Synthesis, and Evaluation of Antinociceptive Properties of Novel CBD-Based Terpene-Cinnamoyl-Acyl-Hydrazone Analogues.新型基于大麻二酚的萜烯-肉桂酰-酰基腙类似物的抗伤害感受特性的设计、合成与评价
Pharmaceuticals (Basel). 2025 May 20;18(5):755. doi: 10.3390/ph18050755.
2
The Potential Use of Cannabidiol in the Treatment of Opioid Use Disorder: A Systematic Review.大麻二酚在治疗阿片类物质使用障碍中的潜在用途:一项系统评价
Addict Biol. 2025 May;30(5):e70047. doi: 10.1111/adb.70047.
3
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years.

本文引用的文献

1
Impact of cannabis use during stabilization on methadone maintenance treatment.大麻使用对美沙酮维持治疗稳定期的影响。
Am J Addict. 2013 Jul-Aug;22(4):344-51. doi: 10.1111/j.1521-0391.2013.12044.x.
2
Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure.应激诱导的皮质肾上腺素能受体敏化后,大麻素暴露的历史。
Exp Neurol. 2012 Aug;236(2):327-35. doi: 10.1016/j.expneurol.2012.05.016. Epub 2012 Jun 4.
3
Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion.
过去25年中CB1R和CB2R配体在睡眠障碍和成瘾行为中的作用
Pharmaceuticals (Basel). 2025 Feb 18;18(2):266. doi: 10.3390/ph18020266.
4
Cannabinoids and General Anesthetics: Revisiting Molecular Mechanisms of Their Pharmacological Interactions.大麻素与全身麻醉药:重新审视它们药理相互作用的分子机制
Anesth Analg. 2024 Nov 6;140(6):1401-13. doi: 10.1213/ANE.0000000000007313.
5
Cannabis use and acute postoperative pain outcomes in older adults: a propensity matched retrospective cohort study.老年人使用大麻与急性术后疼痛结局:一项倾向匹配的回顾性队列研究。
Reg Anesth Pain Med. 2024 Jun 30. doi: 10.1136/rapm-2024-105633.
6
Negative allosteric modulation of CB cannabinoid receptor signaling suppresses opioid-mediated tolerance and withdrawal without blocking opioid antinociception.负变构调节大麻素 CB 受体信号抑制阿片介导的耐受和戒断而不阻断阿片类药物的镇痛作用。
Neuropharmacology. 2024 Oct 1;257:110052. doi: 10.1016/j.neuropharm.2024.110052. Epub 2024 Jun 25.
7
The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder.药用大麻作为阿片类物质使用障碍新兴疗法的作用。
Pain Ther. 2024 Jun;13(3):435-455. doi: 10.1007/s40122-024-00599-1. Epub 2024 Apr 27.
8
Effects of CB1 receptor negative allosteric modulator Org27569 on oxycodone withdrawal symptoms in mice.CB1 受体负变构调节剂 Org27569 对小鼠羟考酮戒断症状的影响。
Psychopharmacology (Berl). 2024 Aug;241(8):1705-1717. doi: 10.1007/s00213-024-06591-z. Epub 2024 Apr 27.
9
Does cannabis use substitute for opioids? A preliminary exploratory survey in opioid maintenance patients.使用大麻能否替代阿片类药物?针对阿片类药物维持治疗患者的初步探索性调查。
Eur Arch Psychiatry Clin Neurosci. 2025 Mar;275(2):565-572. doi: 10.1007/s00406-023-01718-3. Epub 2024 Mar 19.
10
The Therapeutic Potential of Cannabidiol in Revolutionising Opioid Use Disorder Management.大麻二酚在革新阿片类药物使用障碍管理方面的治疗潜力。
Cureus. 2023 Dec 16;15(12):e50634. doi: 10.7759/cureus.50634. eCollection 2023 Dec.
直接向伏隔核内输注β-肾上腺素能受体拮抗剂可消除 WIN 55,212-2 引起的厌恶。
Neurosci Lett. 2011 Aug 1;500(1):82-5. doi: 10.1016/j.neulet.2011.06.008. Epub 2011 Jun 15.
4
Type I cannabinoid receptor trafficking: all roads lead to lysosome.I 型大麻素受体转运:条条大路通溶酶体。
Traffic. 2011 Jan;12(1):12-8. doi: 10.1111/j.1600-0854.2010.01130.x. Epub 2010 Nov 3.
5
Medical marijuana 2010: it's time to fix the regulatory vacuum.医用大麻 2010:是时候填补监管空白了。
J Law Med Ethics. 2010 Fall;38(3):654-66. doi: 10.1111/j.1748-720X.2010.00519.x.
6
The multiplicity of action of cannabinoids: implications for treating neurodegeneration.大麻素的多种作用:治疗神经退行性疾病的意义。
CNS Neurosci Ther. 2011 Dec;17(6):637-44. doi: 10.1111/j.1755-5949.2010.00195.x. Epub 2010 Sep 28.
7
Increased abundance of opioid receptor heteromers after chronic morphine administration.慢性吗啡给药后阿片受体异源二聚体丰度增加。
Sci Signal. 2010 Jul 20;3(131):ra54. doi: 10.1126/scisignal.2000807.
8
Contribution of limbic norepinephrine to cannabinoid-induced aversion.边缘系统去甲肾上腺素对大麻素引起的厌恶的贡献。
Psychopharmacology (Berl). 2010 Sep;211(4):479-91. doi: 10.1007/s00213-010-1923-7. Epub 2010 Jul 3.
9
Differential substance abuse patterns distribute according to gender in heroin addicts.海洛因成瘾者的物质滥用模式存在性别差异。
J Psychoactive Drugs. 2010 Mar;42(1):89-95. doi: 10.1080/02791072.2010.10399789.
10
Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders.大麻素-多巴胺相互作用在中枢神经系统疾病的发病机制和治疗中的作用。
CNS Neurosci Ther. 2010 Jun;16(3):e72-91. doi: 10.1111/j.1755-5949.2010.00144.x. Epub 2010 Apr 12.